(Q78631170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

Treatment of non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

15 December 2019

main subject

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

Arun J Sanyal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

17 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

S385-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Effect of weight control on hepatic abnormalities in obese patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Nonalcoholic steatohepatitis in obesity: a reversible condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Physical activity and weight maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Effect of taurine on the fatty liver of children with simple obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.32.X

10.1046/J.1440-1746.17.S3.32.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472968%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference